Cannabis stocks are expected to rise with potential new federal regulations on hemp-derived products and indications that President Donald Trump may adopt a more lenient stance on marijuana. Companies like Verano Holdings reported earnings of $203 million but a net loss of $44 million due to various charges. Curaleaf and Trulieve will report earnings next week, with hopes for a sector turnaround. Tilray CEO remains optimistic, citing potential for a true inflection point in the cannabis industry.
Trump’s public support for CBD coverage under Medicare and hints at reclassifying marijuana have fueled optimism in the cannabis market. Cannabis use in the U.S. now surpasses daily drinking, with the industry projected to reach a $160 billion global market by 2032. The 2018 Farm Bill paved the way for the hemp market’s growth, with Congress considering updates for federal standards on labeling and safety measures for hemp-derived products.
A video promoting CBD Medicare coverage shared by Trump, created by cannabis advocate Howard Kessler, sparked a surge in cannabis stock prices. The ‘Trump effect’ has led to speculation about potential support for cannabis reform among Republicans. However, concerns remain about the lack of scientific data on CBD’s effectiveness and unknown effects on certain conditions. The FDA has only approved Epidiolex for rare forms of epilepsy, with other uses still under investigation. Problems arise with CBD products containing high THC levels, targeting kids, and tainted samples. Congress debates hemp bans and THC limits. Tilray CEO advocates for clear rules to eliminate industry uncertainty. Federal standards are seen as crucial to legitimize the market and attract institutional investors.
Trump hints at rescheduling marijuana to a Schedule III drug, which could ease access to banking, financial services, and scientific research. Investor optimism grows due to ties between Trump’s chief of staff and a major cannabis company. Trump’s consideration of rescheduling follows significant donations from the cannabis industry.
Republican lawmakers express safety concerns over hemp-derived products, calling for stricter regulations. Hemp market booms post-2018 but faces oversaturation and safety risks. Legislation is introduced to redefine hemp and exclude products with detectable THC. Uncertainty surrounds the industry as regulations and oversight remain unclear.
The future of the cannabis industry hinges on potential regulatory changes from the Trump administration. Investor optimism is tied to expectations of clearer regulations and enforcement. Congressional proposals aim to address safety concerns and curb the proliferation of hemp products with questionable THC levels. 1. The stock market saw a significant drop today with the S&P 500 falling by 2.5%, marking the biggest one-day decline in months. Investor concerns over rising inflation and interest rates were cited as key factors in the market downturn.
2. The latest jobs report showed a higher-than-expected increase in unemployment claims, with 750,000 new claims filed last week. This rise in jobless claims is a worrying sign for the economic recovery as businesses struggle to bounce back from the pandemic.
3. In international news, tensions between Russia and Ukraine continue to escalate as Russian troops amass near the Ukrainian border. The United States and other Western nations have expressed concern over the military buildup and are calling for a peaceful resolution to the crisis.
4. A new study published in a leading medical journal found that the Pfizer-BioNTech COVID-19 vaccine is highly effective in preventing symptomatic illness and hospitalization. The study showed an efficacy rate of 95% against the original strain of the virus and 91% against the Delta variant.
5. In technology news, Apple announced the release of its latest iPhone model, the iPhone 13. The new device features improved camera capabilities, faster processing speeds, and longer battery life. Pre-orders for the iPhone 13 have already exceeded expectations, with analysts predicting strong sales for the tech giant.
Read more at CNBC
1. Tesla shares soar 6% after reporting record sales in the first quarter. The electric car maker delivered over 184,800 vehicles, exceeding analyst expectations of 177,822 units. Tesla’s stock price reached an all-time high of $695.00 per share.
2. The S&P 500 and Dow Jones Industrial Average close at new record highs as investors remain optimistic about economic recovery. The S&P 500 gains 0.4% to end at 4,128.80, while the Dow rises 0.5% to finish at 33,153.21.
3. Amazon announces plans to open a hair salon in London to test new technologies and services. Customers can experience augmented reality hair consultations and use QR codes to learn more about products. The salon will also showcase Amazon’s own professional beauty products.: ‘Trump effect’ raises hopes for cannabis rally